Literature DB >> 19567715

Opioid metabolism.

Howard S Smith1.   

Abstract

Clinicians understand that individual patients differ in their response to specific opioid analgesics and that patients may require trials of several opioids before finding an agent that provides effective analgesia with acceptable tolerability. Reasons for this variability include factors that are not clearly understood, such as allelic variants that dictate the complement of opioid receptors and subtle differences in the receptor-binding profiles of opioids. However, altered opioid metabolism may also influence response in terms of efficacy and tolerability, and several factors contributing to this metabolic variability have been identified. For example, the risk of drug interactions with an opioid is determined largely by which enzyme systems metabolize the opioid. The rate and pathways of opioid metabolism may also be influenced by genetic factors, race, and medical conditions (most notably liver or kidney disease). This review describes the basics of opioid metabolism as well as the factors influencing it and provides recommendations for addressing metabolic issues that may compromise effective pain management. Articles cited in this review were identified via a search of MEDLINE, EMBASE, and PubMed. Articles selected for inclusion discussed general physiologic aspects of opioid metabolism, metabolic characteristics of specific opioids, patient-specific factors influencing drug metabolism, drug interactions, and adverse events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567715      PMCID: PMC2704133          DOI: 10.1016/S0025-6196(11)60750-7

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  100 in total

1.  Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide action.

Authors:  M S Angst; M Bührer; J Lötsch
Journal:  Anesthesiology       Date:  2000-05       Impact factor: 7.892

Review 2.  Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites.

Authors:  M T Smith
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-07       Impact factor: 2.557

3.  Methadone-induced myoclonus in advanced cancer.

Authors:  N Sarhill; M P Davis; D Walsh; C Nouneh
Journal:  Am J Hosp Palliat Care       Date:  2001 Jan-Feb       Impact factor: 2.500

4.  Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide.

Authors:  A W Wright; L E Mather; M T Smith
Journal:  Life Sci       Date:  2001-06-15       Impact factor: 5.037

5.  Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation.

Authors:  Y Oda; E D Kharasch
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

6.  Identification of hydrocodone in human urine following controlled codeine administration.

Authors:  J M Oyler; E J Cone; R E Joseph; M A Huestis
Journal:  J Anal Toxicol       Date:  2000-10       Impact factor: 3.367

7.  Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance.

Authors:  C R Bhasker; W McKinnon; A Stone; A C Lo; T Kubota; T Ishizaki; J O Miners
Journal:  Pharmacogenetics       Date:  2000-11

8.  Randomized placebo-controlled trial of the activity of the morphine glucuronides.

Authors:  R T Penson; S P Joel; K Bakhshi; S J Clark; R M Langford; M L Slevin
Journal:  Clin Pharmacol Ther       Date:  2000-12       Impact factor: 6.875

9.  Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor.

Authors:  C Gillen; M Haurand; D J Kobelt; S Wnendt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-08       Impact factor: 3.000

10.  Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.

Authors:  S Mercadante; A Casuccio; F Fulfaro; L Groff; R Boffi; P Villari; V Gebbia; C Ripamonti
Journal:  J Clin Oncol       Date:  2001-06-01       Impact factor: 44.544

View more
  148 in total

Review 1.  Implications of opioid analgesia for medically complicated patients.

Authors:  Howard Smith; Patricia Bruckenthal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Prescription of opioids for opioid-naive medical inpatients.

Authors:  Sharan Lail; Kelly Sequeira; Jenny Lieu; Irfan A Dhalla
Journal:  Can J Hosp Pharm       Date:  2014-09

3.  Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for Pharmacists.

Authors:  David S Craig
Journal:  P T       Date:  2010-06

4.  Safe use of opioids to manage pain in patients with cirrhosis.

Authors:  Keith M Swetz; Elise C Carey; Richard H Rho; William D Mauck; Kevin J Whitford; Timothy J Moynihan; Judith S Kaur; Patrick J Coyne; Thomas J Smith
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

5.  Research priorities in geriatric palliative care: nonpain symptoms.

Authors:  Sara Combs; Benzi M Kluger; Jean S Kutner
Journal:  J Palliat Med       Date:  2013-07-26       Impact factor: 2.947

Review 6.  Pain management in the cirrhotic patient: the clinical challenge.

Authors:  Natasha Chandok; Kymberly D S Watt
Journal:  Mayo Clin Proc       Date:  2010-03-31       Impact factor: 7.616

Review 7.  Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Authors:  Adeleke D Adewumi; Christine E Staatz; Samantha A Hollingworth; Jason P Connor; Rosa Alati
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

8.  Contemporary clinical opioid use: opportunities and challenges.

Authors:  William L Lanier; Evan D Kharasch
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 9.  Perioperative Pain Management and Opioid Stewardship: A Practical Guide.

Authors:  Sara J Hyland; Kara K Brockhaus; William R Vincent; Nicole Z Spence; Michelle M Lucki; Michael J Howkins; Robert K Cleary
Journal:  Healthcare (Basel)       Date:  2021-03-16

10.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.